A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention

NCT03817125 ·Status: COMPLETED ·Phase: PHASE1

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

NCT05286294 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

NCT05928962 ·Status: UNKNOWN ·Phase: PHASE1

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT04462406 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Defining the Role of the Skin Microbiome in Immune-related Adverse Events

NCT04734704 ·Status: UNKNOWN ·Phase: NA

Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin

NCT01085396 ·Status: TERMINATED

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00006035 ·Status: UNKNOWN ·Phase: PHASE1

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

NCT01886235 ·Status: COMPLETED ·Phase: NA

A Study of IBI363 in Subjects With Advanced Melanoma

NCT06081920 ·Status: RECRUITING ·Phase: PHASE2

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00729950 ·Status: COMPLETED ·Phase: PHASE1

Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma

NCT00996827 ·Status: TERMINATED

Stage IV Surgery Versus Best Medical Therapy

NCT01013623 ·Status: TERMINATED ·Phase: PHASE3

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

NCT00198276 ·Status: COMPLETED ·Phase: PHASE4

Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

NCT02744209 ·Status: TERMINATED

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

NCT00002860 ·Status: COMPLETED ·Phase: PHASE2

Treatment Use Study for Advanced Melanoma.

NCT00584493 ·Status: NO_LONGER_AVAILABLE

Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study

NCT07050940 ·Status: RECRUITING ·Phase: NA

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

NCT04493723 ·Status: RECRUITING

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

NCT01760499 ·Status: COMPLETED ·Phase: PHASE1

Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII

NCT03818893 ·Status: UNKNOWN ·Phase: PHASE2

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

NCT03003676 ·Status: COMPLETED ·Phase: PHASE1

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

NCT05377905 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

NCT06940739 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

SBRT as a Vaccination for Metastatic Melanoma

NCT04042506 ·Status: WITHDRAWN ·Phase: PHASE2

Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

NCT05402059 ·Status: UNKNOWN